This page last changed on 30.01.2015 by kkuk.

Link to EPIC Elderly cohort description


Contact persons for the cohort description

Prof Petra H Peeters, MD, PhD

Partner

Institute

Dept Epidemiology, Julius center, University Medical Center Utrecht, the Netherlands

Key personnel for CHANCES

Responsible person: Prof Petra H. Peeters

Other Key personnel: Prof Yvonne T. van der Schouw

Definition of the cohort

EPIC Utrecht (OR Prospect-EPIC; One of the two cohorts in EPICnl)

Target population

Women participating in population based breast screening, Utrecht, Netherlands

Recruitment

Invitation by letter

Years of recruitment

1993-97

Size of the cohort

17,537 total, age 49-70 years

Recontacts

Yes

Period

3-5 years after baseline

Approach

By letter

Measurements at baseline and recontacts

Socioeconomic Baseline Recontact 1
Education x  
Income -  
Marital status x  
Occupation -  
Employment status x  
History of Baseline Recontact 1
Diabetes x  
Dyslipidemia    
Coronary heart disease x  
Stroke x  
Cancer x  
Benign neoplasms -  
Fracture x  
- Which site(s)? Hip, wrist, vertebra  
Osteoporosis    
Family history of Baseline Recontact 1
Coronary heart disease -  
Stroke -  
Diabetes -  
Cancer Only breast  
Lifestyle Baseline Recontact 1
Current smoking x  
Past smoking x  
Alcohol use x  
Physical activity x  
Nutrition (yes/no) x  
- Number of food items available (approximately)    
- Method(s) of dietary assessment (e.g. 24h-recall, food frequency questionnaire, dietary records) FFQ, 8% sample 24h-recall  
- Supplement use x  
Anthropometry Baseline Recontact 1
Weight and height x  
- Measured or self-reported measured  
Unintended weight loss -  
Waist circumference x  
- Measured or self-reported measured  
Hip circumference x  
Measured or self-reported measured  
Blood pressure Baseline Recontact 1
Measured blood pressure x  
History of hypertension x  
Blood tests Baseline Recontact 1
Total cholesterol -  
HDL cholesterol -  
Triglycerides -  
- Fasting period -  
ApoA1 -  
ApoB -  
Glucose -  
- Fasting period -  
Glucose tolerance test -  
HbA1c -  
GGT -  
CRP -  
25-Hydroxy-Vitamin D -  
Other tests (specify) -  
Availability of frozen sera for further analysis x  
- Storage temperature (°C) of sera
Liquid nitrogen  
Availability of frozen plasma for further analysis x  
- Storage temperature (°C) of plasma
Liquid nitrogen  
Genetics Baseline Recontact 1
Genotypic data -  
GWAS (specify) -  
Other high-throughput array data (specify) -  
Availability of DNA for further genotyping -  
Plated DNA -  
Otherwise stored DNA -  
Other measurements Baseline Recontact 1
Perceived health -  
Cognitive decline/dementia -  
Depression -  
Grip Strength -  
Lung function -  
Audiometry -  
Measurement of bone density (DEXA) -  
Quality of life instruments (such as SF-12, EUROQoL) -  
Limitations in ADL/IADL (i.e. Activities of daily living/Instrumental activities of daily living) -  
Multimorbidity instruments (such as CIRS-G) -  
Frailty scales -  
Reproductive history (for women) x  
Menstruation and menopausal status x  
Fertility problems x  
Pregnancies x  
Breast feeding x  
Hysterectomy and ovariectomy x  
History of oral contraceptive use x  
History of menopausal hormones use x  
Current use of exogenous hormones x  
Use of drugs -  
Availability of classification of drugs, specify (e.g. Anatomical Therapeutic Chemical(ATC) classification system) -  
Additional Topics Baseline Recontact 1
     
     

Future recontacts

Planned, only by questionnaire

Other follow-up

Follow-up period

Until 2010 (updated every 2-3 years)

Sources of data

Cancer Registry, Hospital Discharge diagnosis, Municipality Registry

Follow-up procedure

Linkage to registries

End-points covered through the follow-up

  • All deaths: yes
    • Specification of the cause: yes
  • Non-fatal cancers: yes
    • Cancer survival: (combining with all deaths: yes)
  • Non-fatal acute coronary events: yes (hospitalized)
  • Non-fatal stroke: yes (hospitalized)
  • Non-fatal diabetes: yes
  • Fractures: no
  • Cognitive impairment/dementia: no
  • Nursing home admission: no

ICD-version used for classification of diseases in the data

  • Which version was used (if several, specify years and/or data sources for each):

References

1: Boker LK, van Noord PA, van der Schouw YT, Koot NV, Bueno de Mesquita HB, Riboli E, Grobbee DE, Peeters PH. Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 2001;17(11):1047-53. PubMed PMID: 12380720.

2: Beulens JW, Monninkhof EM, Verschuren WM, van der Schouw YT, Smit J, Ocke MC,  Jansen EH, van Dieren S, Grobbee DE, Peeters PH, Bueno-de-Mesquita HB. Cohort profile: the EPIC-NL study. Int J Epidemiol. 2010 Oct;39(5):1170-8. doi: 10.1093/ije/dyp217. Epub 2009 May 29. PubMed PMID: 19483199.

Document generated by Confluence on 26.02.2015 18:13